HomeCompareNDENF vs PFE

NDENF vs PFE: Dividend Comparison 2026

NDENF yields 1250.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NDENF wins by $135327077.54M in total portfolio value
10 years
NDENF
NDENF
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full NDENF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NDENF vs PFE

📍 NDENF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNDENFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NDENF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NDENF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NDENF
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, NDENF beats the other by $99,387,236,888,751.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NDENF + PFE for your $10,000?

NDENF: 50%PFE: 50%
100% PFE50/50100% NDENF
Portfolio after 10yr
$67663538.82M
Annual income
$58,463,080,549,053.55/yr
Blended yield
86.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NDENF
No analyst data
Altman Z
-417.6
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NDENF buys
0
PFE buys
0
No recent congressional trades found for NDENF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNDENFPFE
Forward yield1250.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$135327077.59M$49.6K
Annual income after 10y$116,926,161,071,848.38$26,258.71
Total dividends collected$133960810.96M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NDENF vs PFE ($10,000, DRIP)

YearNDENF PortfolioNDENF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$135,700$125,000.00$9,153$693.39+$126.5KNDENF
2$1,730,479$1,585,280.37$8,593$849.25+$1.72MNDENF
3$20,744,959$18,893,346.29$8,336$1,066.78+$20.74MNDENF
4$233,872,934$211,675,827.14$8,437$1,384.80+$233.86MNDENF
5$2,480,500,804$2,230,256,765.05$9,013$1,875.40+$2480.49MNDENF
6$24,761,170,753$22,107,034,892.35$10,306$2,680.72+$24761.16MNDENF
7$232,737,122,500$206,242,669,794.36$12,820$4,101.38+$232737.11MNDENF
8$2,060,741,008,119$1,811,712,287,044.72$17,673$6,826.70+$2060740.99MNDENF
9$17,197,118,239,637$14,992,125,360,949.39$27,543$12,591.86+$17197118.21MNDENF
10$135,327,077,588,260$116,926,161,071,848.38$49,560$26,258.71+$135327077.54MNDENF

NDENF vs PFE: Complete Analysis 2026

NDENFStock

African Energy Metals Inc., a natural resource company, engages in the acquisition, development, and exploration of mineral properties in the Democratic Republic of Congo (DRC). It explores for copper, cobalt, and lithium energy metals. The company holds 100% interests in six concessions covering an area of 176 square kms located in the southern DRC. It also holds interest in the Manono tin, tantalum, lithium project located in Tanganyika province, Manono district, southeast of the DRC. The company was formerly known as Central African Gold Inc. and changed its name to African Energy Metals Inc. in February 2022. African Energy Metals Inc. is based in Vancouver, Canada.

Full NDENF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NDENF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NDENF vs SCHDNDENF vs JEPINDENF vs ONDENF vs KONDENF vs MAINNDENF vs JNJNDENF vs MRKNDENF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.